Close
  Indian J Med Microbiol
 

Figure 1: Comparison of OS and PFS between HL and NHL (a); comparison of PFS (b) and OS (c) between HL and NHL in male and female patients; comparison of PFS (d) and OS (e) between HL and NHL with CR and with PR; comparison of OS (f) and PFS (g) between HL and NHL with ≤2 and >2 chemotherapy lines. HL: Hodgkin lymphoma, NHL: Non-Hodgkin lymphoma, OS: Overall survival, PFS: Progression-free survival, CR: Complete remission, PR: Partial remission

Figure 1: Comparison of OS and PFS between HL and NHL (a); comparison of PFS (b) and OS (c) between HL and NHL in male and female patients; comparison of PFS (d) and OS (e) between HL and NHL with CR and with PR; comparison of OS (f) and PFS (g) between HL and NHL with ≤2 and >2 chemotherapy lines. HL: Hodgkin lymphoma, NHL: Non-Hodgkin lymphoma, OS: Overall survival, PFS: Progression-free survival, CR: Complete remission, PR: Partial remission